Výsledky vyhledávání - Peng, Chengwei
- Zobrazuji výsledky 1 - 12 z 12
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Prolonged benefit from ipilimumab correlates with improved outcomes from subsequent pembrolizumab Autor Shreders, Amanda, Joseph, Richard, Peng, Chengwei, Ye, Fei, Zhao, Shilin, Puzanov, Igor, Sosman, Jeffrey A., Johnson, Douglas B.
Vydáno 2016Text -
9
Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition Autor Hardeman, Keisha N., Peng, Chengwei, Paudel, Bishal B., Meyer, Christian T., Luong, Thong, Tyson, Darren R., Young, Jamey D., Quaranta, Vito, Fessel, Joshua P.
Vydáno 2017Text -
10
Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review Autor Johnson, Douglas B., Peng, Chengwei, Abramson, Richard G., Ye, Fei, Zhao, Shilin, Wolchok, Jedd D., Sosman, Jeffrey A., Carvajal, Richard D., Ariyan, Charlotte E.
Vydáno 2015Text -
11
Phase I Study of High-Dose l-Methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH Wild-Type High-Grade Glioma Autor Salas, Lucas A., Stewart, Thomas G., Mobley, Bret C., Peng, Chengwei, Liu, Jing, Loganathan, Sudan N., Wang, Jialiang, Ma, Yanjun, Berger, Mitchel S., Absher, Devin, Hu, Yang, Moots, Paul L., Christensen, Brock C., Clark, Stephen W.
Vydáno 2022Text -
12
Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib Autor Han, Han, Li, Shuai, Chen, Ting, Fitzgerald, Michael, Liu, Shengwu, Peng, Chengwei, Tang, Kwan Ho, Cao, Shougen, Chouitar, Johara, Wu, Jiansheng, Peng, David, Deng, Jiehui, Gao, Zhendong, Baker, Theresa E., Li, Fei, Zhang, Hua, Pan, Yuanwang, Ding, Hailin, Hu, Hai, Pyon, Val, Thakurdin, Cassandra, Papadopoulos, Eleni, Tang, Sittinon, Gonzalvez, Francois, Chen, Haiquan, Rivera, Victor M., Brake, Rachael, Vincent, Sylvie, Wong, Kwok-Kin
Vydáno 2021Text